1 January 2021 in Journal of Korean Medical Science
Choi S, et al. J Korean Med Sci. 2021 Jul;36(40):e286. https://doi.org/10.3346/jkms.2021.36.e286
1 January 2023 in Journal of Korean Medical Science
Jeon YH, et al. J Korean Med Sci. 2023 Mar;38(10):e78. https://doi.org/10.3346/jkms.2023.38.e78
15 March 2020 in Journal of Pathology and Translational Medicine
Colorectal epithelial neoplasm extending into the submucosal gut-associated lymphoid tissue (GALT) can cause difficulties in the differential diagnosis. Regarding GALT-associated epithelial neoplasms, a few studies favor the term "GALT carcinoma" while other studies have mentioned the term "GALT-associated pseudoinvasion/epithelial misplacement (PEM)". The clinicopathologic characteristics of 11 cases of colorectal epithelial neoplasm associated with submucosal GALT diagnosed via endoscopic submucosal dissection were studied. Eight cases (72.7%) were in males. The median age was 59 years, and age ranged from 53 to 73. All cases had a submucosal tumor component more compatible with GALT-associated PEM. Eight cases (72.7%) were located in the right colon. Ten cases (90.9%) had a non-protruding endoscopic appearance. Nine cases (81.8%) showed continuity between the submucosal and surface adenomatous components. Nine cases showed (81.8%) focal defects or discontinuation of the muscularis mucosae adjacent to the submucosal GALT. No case showed hemosiderin deposits in the submucosa or desmoplastic reaction. No case showed single tumor cells or small clusters of tumor cells in the submucosal GALT. Seven cases (63.6%) showed goblet cells in the submucosa. No cases showed oncocytic columnar cells lining submucosal glands. Our experience suggests that pathologists should be aware of the differential diagnosis of GALT-associated submucosal extension by colorectal adenomatous neoplasm. Further studies are needed to validate classification of GALT-associated epithelial neoplasms.
21 May 2018 in Journal of Medical Case Reports
Renal oncocytoma is the most common benign renal tumor, and papillary renal cell carcinoma is the second most common histologic subtype of renal cell carcinoma. Renal tumors containing different components such as papillary renal cell carcinoma and oncocytoma are extremely rare. A renal mass was incidentally detected in a 52-year-old Korean woman, and a computed tomographic scan showed a 32-mm multicystic mass with some calcifications in the lower pole of the right kidney. She underwent laparoscopic partial nephrectomy without any perioperative complications. We found a papillary renal cell carcinoma and an oncocytoma in a tumor mass. The possibility of a mixed malignant tumor should be considered while treating benign tumors such as oncocytoma.
30 November 2022 in Korean Journal of Legal Medicine
Shallow water blackout (SWB) is defined as loss of consciousness due to hypoxia during underwater swimming or breath-holding, usually in shallow waters. To date, no cases of SWB-induced drowning have been reported in the Republic of Korea. Here, we report two cases of SWB, followed by drowning, with autopsy findings. Two men, aged 20 (case 1) and 25 (case 2) years, suddenly lost their consciousness during underwater swimming and escape training, respectively. Postmortem examination revealed foamy fluid within trachea and bronchus, pulmonary edema, and sphenoid sinus fluid, which are commonly observed findings in drowning cases. None of the organs in either case showed pathologic alterations, except for hypoplastic coronary artery disease incidentally found in case 2. Pathologists should be aware of this distinct pathologic entity to avoid misdiagnosing the cause or manner of death.
1 April 2026 in Cancer Research Communications
Non–small cell lung cancer (NSCLC) with EGFR L833V/H835L in cis mutation remains poorly understood. We retrospectively reviewed the clinicopathologic features of NSCLC with either EGFR L833V or H835L mutation. The study population includes patients with NSCLC (n = 3,835) at Samsung Medical Center, Seoul, Korea. A total of eight patients with EGFR L833V/H835L in cis mutation were identified. Poorly differentiated histology (either micropapillary or solid patterns) presented in four of five resected cases. Four patients received EGFR tyrosine kinase inhibitors (TKIs) and achieved a median progression-free survival of 13 months. The oncogenic and therapeutic properties of the mutation were investigated through a combination of functional and biochemical analyses, utilizing both in vitro and in vivo models, and structural modeling. The L833V/H835L mutant exhibited oncogenic potential, transforming NIH-3T3 cells and promoting IL3-independent growth in Ba/F3 cells. Furthermore, EGFR TKIs effectively suppressed the mutant’s oncogenic activity in both in vitro and in vivo studies. These phenomena are further supported by its increased kinase activity in structural modeling. Although rare, EGFR L833V/H835L in cis mutation represents a biologically oncogenic and clinically actionable variant in NSCLC. Significance: Our study reveals the rare EGFR L833V/H835L cis mutation as an aggressive oncogenic driver in lung adenocarcinoma, highly responsive to EGFR-directed therapy. These findings provide crucial therapeutic strategies for patients with this specific EGFR variant, addressing a current gap in precision medicine.